{
    "clinical_study": {
        "@rank": "25016", 
        "arm_group": {
            "arm_group_label": "Patient group", 
            "description": "Women with left-sided breast cancer"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this research study is to demonstrate that Deep Inspiration Breath Hold\n      (DIBH), the technique used at the University of North Carolina (UNC) for left-side breast\n      cancer radiation therapy, can reduce side effects to the heart."
        }, 
        "brief_title": "Assessment of Ability of Breath Hold for Left-sided Breast Cancer Radiation Therapy to Reduce Side Effects to Heart", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "The primary objective of this study is to estimate the rate of radiation-associated regional\n      myocardial perfusion defects in patients 6 months after breast/chestwall radiation with DIBH\n      for left-sided breast cancer.  Cardiac perfusion will be assessed using SPECT cardiac\n      perfusion scans pre- and 6 months post-radiation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  signed an Institutional Review Board (IRB)-approved informed consent document for\n             protocol\n\n          -  age >= 18 years\n\n          -  histologically confirmed left-sided breast cancer scheduled to undergo curative\n             intent radiation treatment post lumpectomy or mastectomy\n\n          -  stage 0-III left-sided breast cancer (including DCIS)\n\n          -  SPECT score of 0 at baseline\n\n          -  radiation oncologist agrees target volume coverage will not be compromised via use of\n             the DIBH technique along with conformal field shaping\n\n        Exclusion Criteria:\n\n          -  active cardiac disease, defined as a history of angina, arrhythmias, myocardial\n             infarction, congestive heart failure, or any other cardiac condition, which in the\n             opinion of the treating physician would make this protocol unreasonably hazardous for\n             the patient\n\n          -  symptomatic pulmonary disease currently requiring regular medication including but\n             not restricted to bronchodilators\n\n          -  concurrent chemotherapy\n\n          -  prior receipt of mediastinal radiation therapy\n\n          -  pregnant or lactating women\n\n          -  inability to understand and follow breathing instructions for the DIBH procedure"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Women with left-sided breast cancer"
            }
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01849614", 
            "org_study_id": "LCCC1239"
        }, 
        "intervention": {
            "arm_group_label": "Patient group", 
            "description": "A SPECT cardiac perfusion scan provides a three-dimensional map of blood flow to the heart tissue.  The scan will be taken at rest only.", 
            "intervention_name": "Cardiac SPECT perfusion scan", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 10, 2014", 
        "location": {
            "contact": {
                "email": "xiaoli_tang@med.unc.edu", 
                "last_name": "Lily Tang, PhD", 
                "phone": "919-445-5475"
            }, 
            "contact_backup": {
                "email": "rlgreen@med.unc.edu", 
                "last_name": "Becky Green, MSW", 
                "phone": "919-445-5241"
            }, 
            "facility": {
                "address": {
                    "city": "Chapel Hill", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27599"
                }, 
                "name": "University of North Carolina at Chapel Hill, Department of Radiation Oncology"
            }, 
            "investigator": {
                "last_name": "Timothy M Zagar, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Prospective Pilot Study of Assessment of Breath Hold as a Means to Mitigate the Risk of Radiation-associated Reductions in Regional Cardiac Perfusion in Patients With Left-sided Breast Cancer", 
        "overall_official": {
            "affiliation": "University of North Carolina, Chapel Hill", 
            "last_name": "Timothy M Zagar, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Cardiac perfusion will be assessed using SPECT cardiac perfusion scans pre- and 6 months post-radiation.  Any post-radiation summed-rest score (SRS) > 0 will be counted as a perfusion defect in the calculation of the perfusion defect rate.", 
            "measure": "Changes in cardiac perfusion", 
            "safety_issue": "No", 
            "time_frame": "6-months post radiation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01849614"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The incidence of wall-motion abnormalities will be assessed using SPECT in the same 12 segment scoring system used to quantify perfusion.  Wall-motion abnormalities will be recorded as present or absent in each cardiac segment.  When present, wall-motion abnormalities wil be classified as gypokinetic, akinetic, or dyskinetic.  The extent of wall involvement (small or large portion) will be described as mild or severe.", 
            "measure": "Wall-motion abnormalities", 
            "safety_issue": "No", 
            "time_frame": "6-months post-treatment"
        }, 
        "source": "UNC Lineberger Comprehensive Cancer Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "UNC Lineberger Comprehensive Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}